Pharmacokinetic-pharmacodynamic modelling of the anticonvulsant effect of oxazepam in individual rats. 1990

J Dingemanse, and R A Voskuyl, and M W Langemeijer, and I Postel-Westra, and D D Breimer, and H Meinardi, and M Danhof
Center for Bio-Pharmaceutical Sciences, University of Leiden, The Netherlands.

1. The purpose of this investigation was to examine in vivo drug-concentration anticonvulsant effect relationships of oxazepam in individual rats following administration of a single dose. 2. Whole blood concentration vs time profiles of oxazepam were determined following administration of doses of 4, 8 and 12 mg kg-1. The pharmacokinetics could be described by an open 2-compartment pharmacokinetic model. Following 12 mg kg-1 the values (mean +/- s.e., n = 11) of clearance and volume of distribution were 28 +/- 2 ml min-1 kg-1 and 2.6 +/- 0.31 kg-1, respectively, and were not significantly different from the values obtained at the other doses. 3. The anticonvulsant effect was quantitated by a new technique which allows repetitive determination of the convulsive threshold by direct cortical stimulation within one rat. Significant dose-dependent elevations of the seizure threshold were observed. 4. By pharmacokinetic-pharmacodynamic modelling, a log-linear relationship was found between concentration and anticonvulsant effect. Following 12 mg kg-1 the values (mean +/- s.e., n = 11) of the pharmacodynamic parameters slope and minimal effective concentration (Cmin) were 243 +/- 27 microA and 0.11 +/- 0.02 mg l-1, respectively and not significantly different from the values obtained at the other doses. 5. In a repeatability study the pharmacodynamic parameters were determined twice on two different occasions with an interval of two weeks in the same group of 11 rats. The inter-animal variability in the pharmacodynamic parameter slope was 46%, whereas the intra-animal variability was 24 +/- 18%. The value of the minimal effective concentration was in each animal and on each occasion close to zero within the relatively narrow range of 0.01-0.30mgI. 6. The results of this study showed that it is possible to determine in vivo concentration-anticonvulsant effect relationships of oxazepam under non-steady-state conditions in individual rats. The anti-convulsant effect of oxazepam appeared to be a rapidly reversible direct effect and acute tolerance did not develop within the time frame of the experiments.

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010076 Oxazepam A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia. Adumbran,Serax,Tazepam
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

J Dingemanse, and R A Voskuyl, and M W Langemeijer, and I Postel-Westra, and D D Breimer, and H Meinardi, and M Danhof
April 1988, Journal of pharmacokinetics and biopharmaceutics,
J Dingemanse, and R A Voskuyl, and M W Langemeijer, and I Postel-Westra, and D D Breimer, and H Meinardi, and M Danhof
December 2005, Fundamental & clinical pharmacology,
J Dingemanse, and R A Voskuyl, and M W Langemeijer, and I Postel-Westra, and D D Breimer, and H Meinardi, and M Danhof
October 1997, Journal of pharmacological and toxicological methods,
J Dingemanse, and R A Voskuyl, and M W Langemeijer, and I Postel-Westra, and D D Breimer, and H Meinardi, and M Danhof
September 1992, British journal of pharmacology,
J Dingemanse, and R A Voskuyl, and M W Langemeijer, and I Postel-Westra, and D D Breimer, and H Meinardi, and M Danhof
February 1998, The Journal of pharmacology and experimental therapeutics,
J Dingemanse, and R A Voskuyl, and M W Langemeijer, and I Postel-Westra, and D D Breimer, and H Meinardi, and M Danhof
November 2020, Scientific reports,
J Dingemanse, and R A Voskuyl, and M W Langemeijer, and I Postel-Westra, and D D Breimer, and H Meinardi, and M Danhof
January 2015, British journal of clinical pharmacology,
J Dingemanse, and R A Voskuyl, and M W Langemeijer, and I Postel-Westra, and D D Breimer, and H Meinardi, and M Danhof
January 1993, British journal of anaesthesia,
J Dingemanse, and R A Voskuyl, and M W Langemeijer, and I Postel-Westra, and D D Breimer, and H Meinardi, and M Danhof
January 2009, Clinical pharmacokinetics,
J Dingemanse, and R A Voskuyl, and M W Langemeijer, and I Postel-Westra, and D D Breimer, and H Meinardi, and M Danhof
March 1991, British journal of pharmacology,
Copied contents to your clipboard!